260 related articles for article (PubMed ID: 36484987)
1. Trends in Risk Factors and Symptoms Associated With SARS-CoV-2 and Rhinovirus Test Positivity in King County, Washington, June 2020 to July 2022.
Hansen C; Perofsky AC; Burstein R; Famulare M; Boyle S; Prentice R; Marshall C; McCormick BJJ; Reinhart D; Capodanno B; Truong M; Schwabe-Fry K; Kuchta K; Pfau B; Acker Z; Lee J; Sibley TR; McDermot E; Rodriguez-Salas L; Stone J; Gamboa L; Han PD; Duchin JS; Waghmare A; Englund JA; Shendure J; Bedford T; Chu HY; Starita LM; Viboud C
JAMA Netw Open; 2022 Dec; 5(12):e2245861. PubMed ID: 36484987
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 infection following booster vaccination: Illness and symptom profile in a prospective, observational community-based case-control study.
Antonelli M; Penfold RS; Canas LDS; Sudre C; Rjoob K; Murray B; Molteni E; Kerfoot E; Cheetham N; Pujol JC; Polidori L; May A; Wolf J; Modat M; Spector T; Hammers A; Ourselin S; Steves C
J Infect; 2023 Dec; 87(6):506-515. PubMed ID: 37777159
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 Symptoms and Duration of Rapid Antigen Test Positivity at a Community Testing and Surveillance Site During Pre-Delta, Delta, and Omicron BA.1 Periods.
Marquez C; Kerkhoff AD; Schrom J; Rojas S; Black D; Mitchell A; Wang CY; Pilarowski G; Ribeiro S; Jones D; Payan J; Manganelli S; Rojas S; Lemus J; Jain V; Chamie G; Tulier-Laiwa V; Petersen M; DeRisi J; Havlir DV
JAMA Netw Open; 2022 Oct; 5(10):e2235844. PubMed ID: 36215069
[TBL] [Abstract][Full Text] [Related]
4. Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.
Accorsi EK; Britton A; Fleming-Dutra KE; Smith ZR; Shang N; Derado G; Miller J; Schrag SJ; Verani JR
JAMA; 2022 Feb; 327(7):639-651. PubMed ID: 35060999
[TBL] [Abstract][Full Text] [Related]
5. Association of mRNA Vaccination With Clinical and Virologic Features of COVID-19 Among US Essential and Frontline Workers.
; Thompson MG; Yoon SK; Naleway AL; Meece J; Fabrizio TP; Caban-Martinez AJ; Burgess JL; Gaglani M; Olsho LEW; Bateman A; Lundgren J; Grant L; Phillips AL; Groom HC; Stefanski E; Solle NS; Ellingson K; Lutrick K; Dunnigan K; Wesley MG; Guenther K; Hunt A; Mak J; Hegmann KT; Kuntz JL; Bissonnette A; Hollister J; Rose S; Morrill TC; Respet K; Fowlkes AL; Thiese MS; Rivers P; Herring MK; Odean MJ; Yoo YM; Brunner M; Bedrick EJ; Fleary DE; Jones JT; Praggastis J; Romine J; Dickerson M; Khan SM; Lamberte JM; Beitel S; Webby RJ; Tyner HL
JAMA; 2022 Oct; 328(15):1523-1533. PubMed ID: 36255426
[TBL] [Abstract][Full Text] [Related]
6. Severity of Illness in Persons Infected With the SARS-CoV-2 Delta Variant vs Beta Variant in Qatar.
Butt AA; Dargham SR; Chemaitelly H; Al Khal A; Tang P; Hasan MR; Coyle PV; Thomas AG; Borham AM; Concepcion EG; Kaleeckal AH; Latif AN; Bertollini R; Abou-Samra AB; Abu-Raddad LJ
JAMA Intern Med; 2022 Feb; 182(2):197-205. PubMed ID: 34935861
[TBL] [Abstract][Full Text] [Related]
7. Disparities and Temporal Trends in COVID-19 Exposures and Mitigating Behaviors Among Black and Hispanic Adults in an Urban Setting.
Badri S; Sardá V; Moncada JS; Merçon M; Rezai K; Weinstein RA; Trick WE
JAMA Netw Open; 2021 Sep; 4(9):e2125187. PubMed ID: 34581798
[TBL] [Abstract][Full Text] [Related]
8. Association of Prior BNT162b2 COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection in Children and Adolescents During Omicron Predominance.
Fleming-Dutra KE; Britton A; Shang N; Derado G; Link-Gelles R; Accorsi EK; Smith ZR; Miller J; Verani JR; Schrag SJ
JAMA; 2022 Jun; 327(22):2210-2219. PubMed ID: 35560036
[TBL] [Abstract][Full Text] [Related]
9. Whom Should We Test for COVID-19? Performance of a Symptom and Risk Factor Questionnaire on COVID-19 Test Results and Patient Outcomes in an Immediate Care Setting.
Oshman L; Caplan A; Ali R; Singh L; Khalid R; Jameel M; David SP
J Prim Care Community Health; 2020; 11():2150132720981297. PubMed ID: 33300408
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Symptoms and RNA Levels in Children and Adults With SARS-CoV-2 Infection in the Community Setting.
Chung E; Chow EJ; Wilcox NC; Burstein R; Brandstetter E; Han PD; Fay K; Pfau B; Adler A; Lacombe K; Lockwood CM; Uyeki TM; Shendure J; Duchin JS; Rieder MJ; Nickerson DA; Boeckh M; Famulare M; Hughes JP; Starita LM; Bedford T; Englund JA; Chu HY
JAMA Pediatr; 2021 Oct; 175(10):e212025. PubMed ID: 34115094
[TBL] [Abstract][Full Text] [Related]
11. Association of a Third Dose of BNT162b2 Vaccine With Incidence of SARS-CoV-2 Infection Among Health Care Workers in Israel.
Spitzer A; Angel Y; Marudi O; Zeltser D; Saiag E; Goldshmidt H; Goldiner I; Stark M; Halutz O; Gamzu R; Slobodkin M; Amrami N; Feigin E; Elbaz M; Furman M; Bronstein Y; Chikly A; Eshkol A; Furer V; Mayer T; Meijer S; Melloul A; Mizrahi M; Yakubovsky M; Rosenberg D; Safir A; Spitzer L; Taleb E; Elkayam O; Silberman A; Eviatar T; Elalouf O; Levinson T; Pozyuchenko K; Itzhaki-Alfia A; Sprecher E; Ben-Ami R; Henig O
JAMA; 2022 Jan; 327(4):341-349. PubMed ID: 35006256
[TBL] [Abstract][Full Text] [Related]
12. Long-Term Symptoms Associated With SARS-CoV-2 Infection Among Blood Donors.
Shah MM; Spencer BR; James-Gist J; Haynes JM; Feldstein LR; Stramer SL; Jones JM; Saydah SH
JAMA Netw Open; 2024 Apr; 7(4):e245611. PubMed ID: 38587842
[TBL] [Abstract][Full Text] [Related]
13. Assessment of Seroprevalence of SARS-CoV-2 and Risk Factors Associated With COVID-19 Infection Among Outpatients in Virginia.
Rogawski McQuade ET; Guertin KA; Becker L; Operario D; Gratz J; Guan D; Khan F; White J; McMurry TL; Shah B; Garofalo S; Southerland M; Bear K; Brush J; Allen C; Frayser A; Vokes R; Pershad R; Peake L; deFilippi C; Barackman K; Bearman G; Bidanset A; Farrell F; Trump D; Houpt ER
JAMA Netw Open; 2021 Feb; 4(2):e2035234. PubMed ID: 33555331
[TBL] [Abstract][Full Text] [Related]
14. Risk Factors Associated With SARS-CoV-2 Seropositivity Among US Health Care Personnel.
Jacob JT; Baker JM; Fridkin SK; Lopman BA; Steinberg JP; Christenson RH; King B; Leekha S; O'Hara LM; Rock P; Schrank GM; Hayden MK; Hota B; Lin MY; Stein BD; Caturegli P; Milstone AM; Rock C; Voskertchian A; Reddy SC; Harris AD
JAMA Netw Open; 2021 Mar; 4(3):e211283. PubMed ID: 33688967
[TBL] [Abstract][Full Text] [Related]
15. Risk Factors Associated With SARS-CoV-2 Infection Among Farmworkers in Monterey County, California.
Mora AM; Lewnard JA; Kogut K; Rauch SA; Hernandez S; Wong MP; Huen K; Chang C; Jewell NP; Holland N; Harris E; Cuevas M; Eskenazi B;
JAMA Netw Open; 2021 Sep; 4(9):e2124116. PubMed ID: 34524438
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous manifestations of SARS-CoV-2 infection during the Delta and Omicron waves in 348 691 UK users of the UK ZOE COVID Study app.
Visconti A; Murray B; Rossi N; Wolf J; Ourselin S; Spector TD; Freeman EE; Bataille V; Falchi M
Br J Dermatol; 2022 Dec; 187(6):900-908. PubMed ID: 35869671
[TBL] [Abstract][Full Text] [Related]
17. Disparities in Seroprevalence of SARS-CoV-2 Immunoglobulin Antibodies in a Large Midwestern Health Care System.
Fitzpatrick V; Rivelli A; Blair C; Copeland K; Richards J
Public Health Rep; 2021 May; 136(3):361-367. PubMed ID: 33673779
[TBL] [Abstract][Full Text] [Related]
18. Association of COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection by Time Since Vaccination and Delta Variant Predominance.
Britton A; Fleming-Dutra KE; Shang N; Smith ZR; Dorji T; Derado G; Accorsi EK; Ajani UA; Miller J; Schrag SJ; Verani JR
JAMA; 2022 Mar; 327(11):1032-1041. PubMed ID: 35157002
[TBL] [Abstract][Full Text] [Related]
19. Association of Maternal Perinatal SARS-CoV-2 Infection With Neonatal Outcomes During the COVID-19 Pandemic in Massachusetts.
Angelidou A; Sullivan K; Melvin PR; Shui JE; Goldfarb IT; Bartolome R; Chaudhary N; Vaidya R; Culic I; Singh R; Yanni D; Patrizi S; Hudak ML; Parker MG; Belfort MB
JAMA Netw Open; 2021 Apr; 4(4):e217523. PubMed ID: 33890989
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 infection during the delta (B.1.617.2) variant surge in India: a test-negative, case-control study and a mechanistic study of post-vaccination immune responses.
Thiruvengadam R; Awasthi A; Medigeshi G; Bhattacharya S; Mani S; Sivasubbu S; Shrivastava T; Samal S; Rathna Murugesan D; Koundinya Desiraju B; Kshetrapal P; Pandey R; Scaria V; Kumar Malik P; Taneja J; Binayke A; Vohra T; Zaheer A; Rathore D; Ahmad Khan N; Shaman H; Ahmed S; Kumar R; Deshpande S; Subramani C; Wadhwa N; Gupta N; Pandey AK; Bhattacharya J; Agrawal A; Vrati S; Bhatnagar S; Garg PK;
Lancet Infect Dis; 2022 Apr; 22(4):473-482. PubMed ID: 34838183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
